Clinical Trials

46 enrolled

Solid Tumors

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Advanced Solid Tumour

NCT07196644 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

125 enrolled

Solid Tumors Harboring MET Amplification

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Advanced Malignant Solid Tumor

NCT07331155 2026-03-09

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

110 enrolled

Advanced Solid Tumour

NCT01761929 2026-03-06

5fr SBRT

138 enrolled

Solid Tumors With Oligometastatic Spread

NCT04589845 2026-03-06

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

920 enrolled 1 FDA

Solid Tumors

NCT01843374 2026-03-05

Tremelimumab

571 enrolled 19 charts

Diabetes Mellitus, Insulin-Dependent, 12, Mesothelioma, Malignant

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

20 enrolled

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT05960773 2026-03-04

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Phase 2 Suspended

9 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT07246863 2026-03-04

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

131 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

Unresectable Solid Tumors

NCT07028281 2026-03-03

A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

120 enrolled

Malignant Solid Tumors

NCT06410209 2026-02-27

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

190 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

90 enrolled

High-Burden Metastatic Solid Tumors

NCT06827054 2026-02-18

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

20 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

60 enrolled

Solid Tumors

NCT06629584 2026-02-17

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

40 enrolled

Malignant Solid Tumors

NCT06651593 2026-02-17

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

40 enrolled

Solid Tumors

NCT07415031 2026-02-17

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT05631262 2026-02-13

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

321 enrolled

Selected Subjects With Advanced Solid Tumors

NCT02934568 2026-02-12

Ribociclib (LEE011) Rollover Study for Continued Access

22 enrolled

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

NCT06783647 2026-02-12

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

230 enrolled

Advanced Solid Tumour

NCT07234058 2026-02-11

LAG-MAPS

126 enrolled

Mesothelioma, Malignant

NCT05661578 2026-02-09

SKYSCRAPER-11

64 enrolled

PD-L1-selected Solid Tumors

NCT06534190 2026-02-09

CD8 PET Imaging in Metastatic Solid Tumours

30 enrolled

Locally Advanced Solid Tumor

NCT07390383 2026-02-09

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT04375228 2026-02-06

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

8 enrolled

Immune-related Adverse Events

NCT02662504 2026-02-05

MesoPDT

6 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT04083976 2026-02-04

RAGNAR

316 enrolled 15 charts

Advanced Solid Tumor

NCT04999969 2026-02-03

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

126 enrolled 30 charts

Locally Advanced or Metastatic Solid Tumours

NCT05419375 2026-02-03

Screening Study for Participants With Malignant Tumors

470 enrolled

Solid Tumors

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

16 enrolled 16 charts

Solid Tumor, Adult

NCT05136677 2026-01-23

CheckMate 6DW

102 enrolled

Mesothelioma, Malignant

NCT07359820 2026-01-22

ReFocus202

30 enrolled

FGFR2 Gene Fusion/Rearrangement

NCT04617054 2026-01-21

Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion

Phase 2 Terminated

14 enrolled

GastrointestinalOther solid neoplasm

Solid Tumor

NCT06006923 2026-01-20

Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

Phase 2 Terminated

1 enrolled

MSI-H Colorectal Cancer

NCT06470971 2026-01-20

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

40 enrolled

Advanced Malignant Solid Neoplasm

NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy